Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
***INTERNAL APPLICATIONS ONLY*** About the Role A 6 month PDRA position is available to study how mitochondrial metabolism regulates cell death in B cell lymphoma. Techniques will include molecular
-
and Immigration website . Full-Time, Fixed-Term (36 months) We are looking for a highly motivated early career researcher with a PhD (or near completion) in psychology, life sciences, genetics
-
About the Role We invite applications for positions at Lecturer and Senior Lecturer level within the Centre for Psychiatry and Mental Health . This is an exciting opportunity to join a leading
-
-luminosity LHC. You will provide support to our PhD students and contribute to the broader activities of the group and the school. About You You will have completed or be about to complete a PhD or research
-
infrastructure enables recruitment of 200-300 severely injured patients annually as part of the ACIT study. We also have a well-established experimental modelling group with full ethical approvals in place for all
-
of Graduate Masters programmes, as well as expanding your knowledge across the range of wider degree programmes. Please note, this is a fixed-term position until September 2026. Main Responsibilities Provide
-
extracellular histone, a damage-associated molecular pattern that is implicated in adverse outcomes after injury. This project will include using a range of clinically relevant models as well as in vitro
-
support the Sample Reception Team in the recording of samples and tests in our electronic laboratory database. The role will require you to follow standard operating procedures (SOPs) to work under aseptic
-
The Role London Business School are thrilled to be recruiting for a motivational and strategic Associate Director, Experiential Learning to join Degree Education on a fixed-term basis. This position
-
About the Role The combination of personalised biophysical models and deep learning techniques with a digital twin approach has the potential to generate new treatments for cardiac diseases. Our